80 related articles for article (PubMed ID: 22034596)
1. Expression of mutant BMPR-II in pulmonary endothelial cells promotes apoptosis and a release of factors that stimulate proliferation of pulmonary arterial smooth muscle cells.
Yang X; Long L; Reynolds PN; Morrell NW
Pulm Circ; 2011; 1(1):103-10. PubMed ID: 22034596
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.
Zhang Q; Yaoita N; Tabuchi A; Liu S; Chen SH; Li Q; Hegemann N; Li C; Rodor J; Timm S; Laban H; Finkel T; Stevens T; Alvarez DF; Erfinanda L; de Perrot M; Kucherenko MM; Knosalla C; Ochs M; Dimmeler S; Korff T; Verma S; Baker AH; Kuebler WM
Circulation; 2024 Jun; ():. PubMed ID: 38873770
[TBL] [Abstract][Full Text] [Related]
3. Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension.
Wu K; Tang H; Lin R; Carr SG; Wang Z; Babicheva A; Ayon RJ; Jain PP; Xiong M; Rodriguez M; Rahimi S; Balistrieri F; Rahimi S; Valdez-Jasso D; Simonson TS; Desai AA; Garcia JGN; Shyy JY; Thistlethwaite PA; Wang J; Makino A; Yuan JX
Pulm Circ; 2020; 10(3):2045894020948470. PubMed ID: 33294172
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanosignaling in pulmonary arterial hypertension.
Wang A; Valdez-Jasso D
Biophys Rev; 2021 Oct; 13(5):747-756. PubMed ID: 34765048
[TBL] [Abstract][Full Text] [Related]
5. BMPR-II mutations promote pulmonary arterial hypertension via a hyperinflammatory response.
Soon E; Crosby A; Southwood M; Pepke-Zaba J; Upton P; Morrell N
Clin Med (Lond); 2015 Jun; 15 Suppl 3():s15. PubMed ID: 26026008
[No Abstract] [Full Text] [Related]
6. BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension.
Diebold I; Hennigs JK; Miyagawa K; Li CG; Nickel NP; Kaschwich M; Cao A; Wang L; Reddy S; Chen PI; Nakahira K; Alcazar MA; Hopper RK; Ji L; Feldman BJ; Rabinovitch M
Cell Metab; 2015 Apr; 21(4):596-608. PubMed ID: 25863249
[TBL] [Abstract][Full Text] [Related]
7. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
Long L; Ormiston ML; Yang X; Southwood M; Gräf S; Machado RD; Mueller M; Kinzel B; Yung LM; Wilkinson JM; Moore SD; Drake KM; Aldred MA; Yu PB; Upton PD; Morrell NW
Nat Med; 2015 Jul; 21(7):777-85. PubMed ID: 26076038
[TBL] [Abstract][Full Text] [Related]
8. Future Perspectives of Pulmonary Arterial Hypertension: A Review of Novel Pipeline Treatments and Indications.
Novara ME; Di Martino E; Stephens B; Nayrouz M; Vitulo P; Carollo A; Provenzani A
Drugs R D; 2024 Mar; 24(1):13-28. PubMed ID: 38514585
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in
Tielemans B; Wagenaar A; Belge C; Delcroix M; Quarck R
Pulm Circ; 2023 Oct; 13(4):e12293. PubMed ID: 37790139
[TBL] [Abstract][Full Text] [Related]
10. Molecular regulation and therapeutic implications of cell death in pulmonary hypertension.
Wang E; Zhou S; Zeng D; Wang R
Cell Death Discov; 2023 Jul; 9(1):239. PubMed ID: 37438344
[TBL] [Abstract][Full Text] [Related]
11. An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension.
Upton PD; Dunmore BJ; Li W; Morrell NW
Dev Dyn; 2023 Mar; 252(3):327-342. PubMed ID: 35434863
[TBL] [Abstract][Full Text] [Related]
12. Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension.
Fazal S; Bisserier M; Hadri L
Cells; 2021 Mar; 10(3):. PubMed ID: 33805595
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
Kurakula K; Smolders VFED; Tura-Ceide O; Jukema JW; Quax PHA; Goumans MJ
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33435311
[TBL] [Abstract][Full Text] [Related]
14. Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention.
Sanada TJ; Sun XQ; Happé C; Guignabert C; Tu L; Schalij I; Bogaard HJ; Goumans MJ; Kurakula K
Cells; 2021 Jan; 10(1):. PubMed ID: 33419137
[TBL] [Abstract][Full Text] [Related]
15. Heart‑lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review).
Ye W; Guo H; Xu J; Cai S; He Y; Shui X; Huang S; Luo H; Lei W
Int J Mol Med; 2020 Sep; 46(3):913-924. PubMed ID: 32582962
[TBL] [Abstract][Full Text] [Related]
16. Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets-From Bench to Bed Site.
Gajecki D; Gawrys J; Szahidewicz-Krupska E; Doroszko A
Oxid Med Cell Longev; 2020; 2020():7265487. PubMed ID: 32566097
[TBL] [Abstract][Full Text] [Related]
17. TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family.
Rol N; Kurakula KB; Happé C; Bogaard HJ; Goumans MJ
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200294
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation alters susceptibility to pulmonary hypertension in Bmpr2-deficient mice.
Crosby A; Toshner MR; Southwood MR; Soon E; Dunmore BJ; Groves E; Moore S; Wright P; Ottersbach K; Bennett C; Guerrero J; Ghevaert C; Morrell NW
Pulm Circ; 2018; 8(4):2045894018801642. PubMed ID: 30160594
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Arterial Hypertension: Iron Matters.
Ramakrishnan L; Pedersen SL; Toe QK; Quinlan GJ; Wort SJ
Front Physiol; 2018; 9():641. PubMed ID: 29904352
[TBL] [Abstract][Full Text] [Related]
20. Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension.
Pousada G; Lupo V; Cástro-Sánchez S; Álvarez-Satta M; Sánchez-Monteagudo A; Baloira A; Espinós C; Valverde D
Sci Rep; 2017 May; 7(1):1923. PubMed ID: 28507310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
